Updated Jul 16, 2026
Miller Joseph M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Joseph M. Miller is identified in the SEC filing context as the Chief Financial Officer of Aurinia Pharmaceuticals Inc. as of the filing dated March 3, 2026. The available SEC context confirms his role and the company, but does not provide additional verified biographical details such as prior positions, education, or career history.
| Role | Chief Financial Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 37.5K | $14.21 | $533K |
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | A — Grant or award | 57.2K | $0.00 | |
| 2026-02-23 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 32.4K | $14.40 | $467K |
Joseph M. Miller is identified in the SEC filing context as the Chief Financial Officer of Aurinia Pharmaceuticals Inc. as of the filing dated March 3, 2026. The available SEC context confirms his role and the company, but does not provide additional verified biographical details such as prior positions, education, or career history.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Miller Joseph M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.